ONK Therapeutics

ONK Therapeutics was founded in 2015 with the goal of developing novel cancer therapies by leveraging natural killer (NK) cells. NK cells are one of the strongest defenses the human body has against cancer and are among the most cytotoxic components of the human immune system against tumor cells. The company’s strategy is to develop innovative cancer therapies based on NK cells. In addition, the company is seeking to enhance these NK cells by introducing a series of genetic modifications, thereby creating a technological platform adaptable to various types of cancer.